|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 31/506 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 25/28 | (2018.01) |
| (11) | Number of the document | 3823623 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19768898.9 |
| Date of filing the European patent application | 2019-07-19 | |
| (97) | Date of publication of the European application | 2021-05-26 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2019/056198 |
| Date | 2019-07-19 |
| (87) | Number | WO 2020/016850 |
| Date | 2020-01-23 |
| (30) | Number | Date | Country code |
| 201862700977 P | 2018-07-20 | US | |
| 201862730184 P | 2018-09-12 | US | |
| 201962839273 P | 2019-04-26 | US |
| (72) |
DYROFF, Martin , US
MITCHELL, David , US
PAPASOULIOTIS, Orestis , CH
|
| (73) |
Merck Patent GmbH ,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | A SUBSTITUTED AMINO-PYRIMIDINE COMPOUND FOR USE IN A METHOD FOR TREATMENT AND PREVENTION OF MULTIPLE SCLEROSIS |
| A SUBSTITUTED AMINO-PYRIMIDINE COMPOUND FOR USE IN A METHOD FOR TREATMENT AND PREVENTION OF MULTIPLE SCLEROSIS |